AtriCure

AtriCure

Health Care Equipment & Supplies
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

$2.8B

Market Cap • 9/11/2026

2000

(26 years)

Founded

2005

(21 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

5,4

P/S

4,9

P/EBITDA

82,4

P/OCF

42,8

P/FCF

52,3

P/E

260,2

BVPS

10,6

EPS

0,2

Market Cap

Market Cap

2,8B

EV

2,7B

EV/Revenue

4,7

EV/EBITDA

79,5

EV/EBIT

208,2

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0,2%

Total Yield

0,2%

Payout

0%

Retained Earnings

-404,1M

Profitability

Gross Margin

76,3%

EBITDA Margin

5,9%

EBIT Margin

2,3%

Net Margin

1,9%

D&A/EBITDA

0%

R&D/Revenue

17,2%

Capex/Revenue

2,1%

Capex/D&A

56,7%

Capex/OCF

18,2%

SBC/OCF

72,8%

% PPE

7,2%

% Goodwill

34,7%

ROE

2,2%

ROIC

2,6%

Growth

CAGR Revenue 5Y

18,6%

Leverage

N.D./EBITDA

Debt/Equity

0%

Current Ratio

4,2

Quick Ratio

3

Interest Coverage

229%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium